Pik Leng Wong
About Pik Leng Wong
Pik Leng Wong serves as the Senior Director, Head of CMC Program Management & Operational Excellence at AlloVir, bringing extensive experience in strategic planning and leadership within the pharmaceutical and biotechnology sectors.
Current Role at AlloVir
Pik Leng Wong serves as Senior Director, Head of CMC Program Management & Operational Excellence at AlloVir since 2020. In this role, Wong oversees the Chemistry, Manufacturing, and Controls (CMC) program management, which is essential for the development and manufacturing of pharmaceuticals. Wong's leadership is instrumental in ensuring operational excellence within the organization.
Previous Experience at Sanofi
Wong has extensive experience at Sanofi, where he held multiple positions. He served as Director of the Global Portfolio Management Office for the Biologics Platform from 2019 to 2020. Prior to that, he was the Head of the Portfolio Management Office and Operational Excellence at the operations site from 2018 to 2019. Wong also worked as the Head of the Portfolio Management Office at Sanofi from 2014 to 2018.
Background in Biotechnology and Pharmaceuticals
Wong has a strong background in the pharmaceutical industry, with a proven track record in managing cross-functional teams. His expertise includes strategic planning and operational excellence, which contribute to the successful management of complex projects in the biotechnology sector. Wong's experience spans various roles that emphasize efficiency and effectiveness in pharmaceutical operations.
Education and Expertise
Wong holds a Master of Science (MS) in Chemical Engineering from Northeastern University, which he obtained from 1999 to 2001. He also earned a Bachelor of Science (BS) in Chemical Engineering from the same institution, completing his studies from 1995 to 1999. His educational background supports his expertise in CMC program management and operational excellence.
Career Progression at Genzyme
Before his tenure at Sanofi, Wong worked at Genzyme, where he progressed from Process Engineer to Principal Process Engineer from 2001 to 2009. This role provided him with foundational experience in process engineering within the biotechnology sector, further enhancing his capabilities in project management and operational efficiency.